Description

This grant opportunity seeks to fund empirical research on the effectiveness, safety, and acceptability of ulipristal acetate (UPA) and misoprostol as an alternative regimen for medication abortion. The purpose is to generate evidence that can inform clinical practice, public policy, and health services delivery, particularly in light of changing legal and regulatory contexts affecting mifepristone access in the United States. Projects may use interventional or observational designs and can be conducted in diverse settings such as telehealth, clinics, or pharmacies. Proposals must detail outcome measurement, study design rationale, participant retention strategies, and address how the research could influence real-world abortion care.